MEAI
MEAI[edit | edit source]
MEAI (5-Methoxy-2-aminoindane) is a psychoactive substance that belongs to the class of amphetamine derivatives. It is known for its unique effects, which are distinct from other stimulants and entactogens. MEAI has been studied for its potential use in reducing alcohol consumption and as a novel psychoactive substance.
Chemical Structure and Properties[edit | edit source]
MEAI is chemically related to the amphetamine family, characterized by the presence of a methoxy group at the 5-position of the indane ring. The chemical structure of MEAI is similar to that of other substituted amphetamines, but it features an indane backbone instead of the typical phenethylamine structure. This modification is believed to contribute to its unique pharmacological profile.
Pharmacology[edit | edit source]
The pharmacological effects of MEAI are not fully understood, but it is thought to act as a serotonin and dopamine releasing agent. Unlike traditional stimulants, MEAI is reported to produce a calming effect, which may be beneficial in reducing alcohol consumption. This effect is hypothesized to be due to its action on the serotonin receptors, which play a role in mood regulation and impulse control.
Potential Uses[edit | edit source]
MEAI has been investigated for its potential use in treating alcohol use disorder. Preliminary studies suggest that MEAI may help reduce the desire to consume alcohol by modulating the reward pathways in the brain. This makes it a candidate for further research in the development of treatments for substance use disorders.
Legal Status[edit | edit source]
The legal status of MEAI varies by country. In some jurisdictions, it is classified as a controlled substance due to its psychoactive properties, while in others, it remains unregulated. Researchers and policymakers continue to evaluate its safety and potential therapeutic benefits.
Safety and Side Effects[edit | edit source]
As with many novel psychoactive substances, the safety profile of MEAI is not well-established. Users have reported both positive and negative effects, including mood enhancement and relaxation, as well as potential side effects such as anxiety and insomnia. Further research is needed to fully understand the risks associated with its use.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
